Lung Cancers Completed Phase 3 Trials for Topotecan (DB01030)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00041015Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00003917Topotecan in Treating Patients With Relapsed Small Cell Lung CancerTreatment